Showing results (1-10 of 52) with videos related to

Sort By:
Pageof 6
Cancers|January 26, 2024
Antibody-Drug Conjugates: The Dynamic Evolution from Conventional to Next-Generation ConstructsVirginia Metrangolo, Lars H Engelholm
Cancers|November 13, 2021
The Urokinase Receptor (uPAR) as a "Trojan Horse" in Targeted Cancer Therapy: Challenges and OpportunitiesVirginia Metrangolo, Michael Ploug, Lars H Engelholm
The Journal of Biological Chemistry|May 20, 2020
The collagen receptor uPARAP/Endo180 regulates collectins through unique structural elements in its FNII domainKirstine Sandal Nørregaard, Oliver Krigslund, Niels Behrendt, et al.
International Journal of Oncology|August 29, 2015
The collagen receptor uPARAP/Endo180 in tissue degradation and cancer (Review)Maria C Melander, Henrik J Jürgensen, Daniel H Madsen, et al.
International Journal of Cancer|March 29, 2002
Urokinase receptor-associated protein (uPARAP) is expressed in connection with malignant as well as benign lesions of the human breast and occurs in specific populations of stromal cellsBoye Schnack Nielsen, Fritz Rank, Lars H Engelholm, et al.
Experimental Cell Research|January 20, 2004
uPARAP/endo180 directs lysosomal delivery and degradation of collagen IVLars Kjøller, Lars H Engelholm, Maria Høyer-Hansen, et al.
Biological Chemistry|July 17, 2008
Dimerization of endogenous MT1-MMP is a regulatory step in the activation of the 72-kDa gelatinase MMP-2 on fibroblasts and fibrosarcoma cellsSigne Ingvarsen, Daniel H Madsen, Thore Hillig, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|May 8, 2009
MT1-MMP and type II collagen specify skeletal stem cells and their bone and cartilage progenyLudmila Szabova, Susan S Yamada, Helen Wimer, et al.
Frontiers in Bioscience (Landmark Edition)|March 11, 2009
The collagen receptor uPARAP/Endo180Lars H Engelholm, Signe Ingvarsen, Henrik J Jürgensen, et al.
Biochemical and Biophysical Research Communications|December 17, 2013
A supra-cellular model for coupling of bone resorption to formation during remodeling: lessons from two bone resorption inhibitors affecting bone formation differentlyPia Rosgaard Jensen, Thomas Levin Andersen, Brenda L Pennypacker, et al.
Pageof 6